Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Yue Ma

4PUBLICATIONS

9CO-AUTHORS

Molecular targetsHaematological tumours

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (4)

Sort by Publication Date:

|Sep 14, 2024

Aberrant SWI/SNF Complex Members Are Predominant in Rare Ovarian Malignancies-Therapeutic Vulnerabilities in Treatment-Resistant Subtypes.

Yue Ma, Natisha R Field, Tao Xie

|Oct 14, 2022

Targeting Homologous Recombination Deficiency in Ovarian Cancer with PARP Inhibitors: Synthetic Lethal Strategies That Impact Overall Survival.

Tao Xie, Kristie-Ann Dickson, Christine Yee

|Aug 27, 2021

PARP Inhibitors Display Differential Efficacy in Models of <i>BRCA</i> Mutant High-Grade Serous Ovarian Cancer.

Kristie-Ann Dickson, Tao Xie, Christian Evenhuis

|Nov 25, 2020

Histone Monoubiquitination in Chromatin Remodelling: Focus on the Histone H2B Interactome and Cancer.

Deborah J Marsh, Yue Ma, Kristie-Ann Dickson

Pageof 1

Frequent Collaborators

4 joint publications

Deborah J Marsh

4 joint publications

Kristie-Ann Dickson

2 joint publications

Tao Xie

2 joint publications

Nikola A Bowden

1 joint publications

Caroline E Ford

1 joint publications

Natisha R Field

1 joint publications

Tali S Skipper

1 joint publications

Amani Alghalayini

1 joint publications

Farhana A Sarker

Frequent Collaborators

4 joint publications

Deborah J Marsh

4 joint publications

Kristie-Ann Dickson

2 joint publications

Tao Xie

2 joint publications

Nikola A Bowden

Top Related Videos

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on : Jul 25, 2020

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on : May 27, 2021

See more related videos

Top Related Videos

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on : Jul 25, 2020

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on : May 27, 2021

See more related videos